Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000229878 is a ***pseudogene similar to part of integrin, beta 2 (ITGB2)***, the gene encoding the integrin beta-2 chain (CD18) that forms part of multiple leukocyte integrins such as LFA-1 and Mac-1[2][3]. Pseudogenes are genetic loci that resemble functional genes but are typically non-coding and do not produce functional protein. They result from duplication or retrotransposition events and are generally considered nonfunctional relics, though some may have regulatory functions in rare cases. There is no evidence this pseudogene is a therapeutic or diagnostic target, nor that it encodes a functional protein involved in immune processes or disease[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on pseudogene similar to part of integrin beta 2.